Cabometyx 20 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FL0D0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $133,060
Award facts
- Contract value 100% obligated
- $133,060.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $133,060.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). Issued on October 29, 2025, with an ultimate completion date of October 30, 2025, this firm fixed-price delivery order was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is registered in the System for Award Management and has demonstrated substantial federal contracting activity as a critical supplier within the Department of Defense pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes delivery orders for a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide, with this Cabometyx delivery representing one of numerous orders fulfilling the specialized pharmaceutical requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FL0D0?
SPE2DB26FL0D0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FL0D0 worth?
The government has obligated $133,060 on SPE2DB26FL0D0.
Is contract SPE2DB26FL0D0 an order under another contract?
Yes. SPE2DB26FL0D0 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB26FL0D0 competed?
The extent of competition for SPE2DB26FL0D0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award